Claraphi Advisory Network’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$503K Buy
3,112
+1,621
+109% +$249K 0.2% 132
2022
Q3
$200K Sell
1,491
-18,086
-92% -$2.6M 0.11% 181
2022
Q2
$3M Buy
19,577
+1,766
+10% +$270K 1.05% 13
2022
Q1
$2.89M Buy
17,811
+8,016
+82% +$1.16M 0.83% 23
2021
Q4
$1.33M Sell
9,795
-718
-7% -$84.8K 0.46% 48
2021
Q3
$1.13M Sell
10,513
-410
-4% -$46.8K 0.4% 51
2021
Q2
$1.23M Sell
10,923
-649
-6% -$73.1K 0.37% 50
2021
Q1
$1.25M Buy
11,572
+432
+4% +$46.2K 0.35% 59
2020
Q4
$1.19M Sell
11,140
-2,162
-16% -$208K 0.33% 56
2020
Q3
$1.17M Sell
13,302
-3,344
-20% -$315K 0.42% 40
2020
Q2
$1.63M Buy
16,646
+5,175
+45% +$456K 0.7% 29
2020
Q1
$874K Buy
11,471
+933
+9% +$79.5K 0.41% 39
2019
Q4
$933K Sell
10,538
-337
-3% -$28K 0.57% 35
2019
Q3
$823K Sell
10,875
-250
-2% -$17.1K 0.5% 41
2019
Q2
$809K Buy
11,125
+1,263
+13% +$99.3K 0.47% 45
2019
Q1
$795K Buy
9,862
+1,318
+15% +$108K 0.5% 42
2018
Q4
$787K Buy
8,544
+607
+8% +$53.4K 0.6% 40
2018
Q3
$751K Buy
7,937
+3,674
+86% +$348K 0.42% 57
2018
Q2
$395K Sell
4,263
-86
-2% -$8.4K 0.25% 105
2018
Q1
$411K Buy
4,349
+716
+20% +$78.7K 0.29% 101
2017
Q4
$351K Buy
+3,633
New +$342K 0.27% 108

Other funds holding ABBV

Claraphi Advisory Network's ABBV Position: Q4 2022 in Review

Claraphi Advisory Network increased its AbbVie (ABBV) stake by 109% in Q4 2022, buying an estimated $249K and bringing the position to 3,112 shares worth $503K. The position accounts for 0.2% of the portfolio, ranked #132.

Claraphi Advisory Network first reported a position in ABBV in Q4 2017 and has held it in 21 quarters since. The position peaked at $3M in Q2 2022. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Claraphi Advisory Network held 3,112 shares of AbbVie worth $503K as of Q4 2022.
  • Claraphi Advisory Network bought 1,621 AbbVie shares in Q4 2022, an estimated $249K.
  • AbbVie made up 0.2% of Claraphi Advisory Network's portfolio in Q4 2022, its #132 holding.
  • Claraphi Advisory Network first reported a position in AbbVie in Q4 2017 and has held it in 21 quarters since.
  • Claraphi Advisory Network's AbbVie position peaked at $3M in Q2 2022.
  • 3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Claraphi Advisory Network's 13F filing for Q4 2022, filed 14 Feb 2023.